CohBar, Inc. Employee Directory
Biotechnology ResearchCalifornia, United States2-10 Employees
CohBar, Inc. is a clinical-stage biotechnology company based in Menlo Park, California. It pursues therapeutics grounded in mitochondrial biology, specifically peptides encoded in the mitochondrial genome, with the aim of addressing chronic and age-related diseases that currently have limited or no treatment options. The company focuses on translating mitochondrial insights into potential medicines for conditions with few effective options. CohBar operates within the biotechnology research sector as a clinical-stage player developing mitochondria-based therapeutics. In 2023, the company announced a definitive merger agreement with Morphogenesis to advance a late-stage oncology/immuno-oncology pipeline.